<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02892955</url>
  </required_header>
  <id_info>
    <org_study_id>MOMENTUM 3 CAP</org_study_id>
    <nct_id>NCT02892955</nct_id>
  </id_info>
  <brief_title>MOMENTUM 3 Continued Access Protocol</brief_title>
  <acronym>MOMENTUM 3 CAP</acronym>
  <official_title>MOMENTUM 3 CAP Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ Continued Access Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thoratec, LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to continue to evaluate safety and clinical performance of the
      HM3 LVAS for the treatment of advanced, refractory, left ventricular heart failure following
      completion of enrollment in the the MOMENTUM 3 IDE Study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The HM3 LVAS is intended to provide hemodynamic support in patients with advanced, refractory
      left ventricular heart failure; either for short term support, such as a bridge to cardiac
      transplantation (BTT) or myocardial recovery, or as long term support, such as destination
      therapy (DT). The HM3 is intended for use inside or outside the hospital.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 Month Survival</measure>
    <time_frame>Subjects will be followed for 6 months or to outcome (transplant, explant, or death), whichever occurs first.</time_frame>
    <description>Composite of survival to transplant, recovery, or LVAD support free of debilitating stroke (Modified Rankin Score &gt; 3) or reoperation to replace the pump at 6 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>24 Month Survival</measure>
    <time_frame>Subjects will be followed for 24 months or to outcome (transplant, explant, or death), whichever occurs first.</time_frame>
    <description>Composite of survival to transplant, recovery, or LVAD support free of debilitating stroke (Modified Rankin Score &gt; 3) or reoperation to replace the pump at 24 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EuroQoL 5D-5L (EQ-5D-5L)</measure>
    <time_frame>Baseline and Months 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Quality of Life as measured by EuroQoL 5D-5L (EQ-5D-5L) will be analyzed at 6 months and 24 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kansas City Cardiomyopathy Questionnaire (KCCQ)</measure>
    <time_frame>Baseline and Months 3, 6, 12, 18 and 24</time_frame>
    <description>Quality of Life as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six Minute Walk Test (6MWT)</measure>
    <time_frame>Baseline and Months 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Functional status as measured by the Six Minute Walk Test (6MWT) will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA</measure>
    <time_frame>Baseline, Initial Hospital Discharge (estimated time frame 30 days), and Months 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Functional status as measured by NYHA classification will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperations</measure>
    <time_frame>As they occur up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of all reoperations will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehospitalizations</measure>
    <time_frame>As they occur up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of all rehospitalizations will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Malfunctions</measure>
    <time_frame>As they occur up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of all device malfunctions will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of all bleeding events will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Arrhythmias</measure>
    <time_frame>As they occur up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of all Cardiac Arrhythmias will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pericardial Fluid Collection</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Pericardial Fluid Collection will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Thrombosis</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Device Thrombosis will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemolysis</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Hemolysis will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hepatic Dysfunction</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Hepatic Dysfunction will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypertension</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Hypertension will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Infection</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Major Infection will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infarction</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Myocardial Infarction will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurologic Dysfunction</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of physician evaluated Neurologic Dysfunctions, or strokes (classified by Modified Rankin Score) will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychiatric Episode</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of physician evaluated Psychiatric Episodes will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal Dysfunction</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Renal Dysfunction will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Failure</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Respiratory Failure will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right Heart Failure</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Right Heart Failure will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial Non-CNS Thromboembolism</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Arterial Non-CNS Thromboembolism will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Venous Thromboembolism Event</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Venous Thromboembolism Events will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound Dehiscence</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Wound Dehiscence will be analyzed at 6 months and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other Adverse Event</measure>
    <time_frame>As it occurs up to 24 months or to outcome, whichever occurs first</time_frame>
    <description>Frequency and incidence of Other Adverse Events that cause clinically relevant changes in the Subject's health (e.g. cancer) will be analyzed at 6 months and 24 months</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Pump Replacement</measure>
    <time_frame>As they occur up to 24 months or to Outcome, whichever occurs first</time_frame>
    <description>In addition to powering the study on the primary endpoints for PMA approval, the study will pre-specify a powered secondary endpoint to evaluate incidence of pump replacements at 24 months.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Advanced Refractory Left Ventricular Heart Failure</condition>
  <arm_group>
    <arm_group_label>Experimental: HeartMate 3 LVAS (HM3 LVAS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study will be a single-arm, prospective, multi-center, study for continued evaluation of safety and clinical performance of the HM3 LVAS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HeartMate 3 LVAS</intervention_name>
    <description>Implantation of HeartMate 3 LVAD to evaluate safety and clinical performance of the HM3 LVAS for the treatment of advanced, refractory, left ventricular heart failure following completion of enrollment in the the MOMENTUM 3 IDE Study.</description>
    <arm_group_label>Experimental: HeartMate 3 LVAS (HM3 LVAS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject or legal representative has signed Informed Consent Form (ICF)

          2. Age ≥ 18 years

          3. BSA ≥ 1.2 m2

          4. NYHA Class III with dyspnea upon mild physical activity or NYHA Class IV

          5. LVEF ≤ 25%

          6. a) Inotrope dependent OR b) CI &lt; 2.2 L/min/m2, while not on inotropes and subjects
             must also meet one of the following:

               -  On optimal medical management (OMM), based on current heart failure practice
                  guidelines for at least 45 out of the last 60 days and are failing to respond

               -  Advanced heart failure for at least 14 days AND dependent on intra-aortic balloon
                  pump (IABP) for at least 7 days,

          7. Females of child bearing age must agree to use adequate contraception

        Exclusion Criteria:

          1. Etiology of HF due to or associated with uncorrected thyroid disease, obstructive
             cardiomyopathy, pericardial disease, amyloidosis, or restrictive cardiomyopathy

          2. Technical obstacles which pose an inordinately high surgical risk, in the judgment of
             the investigator

          3. Existence of ongoing mechanical circulatory support (MCS) other than IABP

          4. Positive pregnancy test if of childbearing potential

          5. Presence of mechanical aortic cardiac valve that will not be either converted to a
             bioprosthesis or oversewn at the time of LVAD implant

          6. History of any organ transplant

          7. Platelet count &lt; 100,000 x 103/L (&lt; 100,000/ml)

          8. Psychiatric disease/disorder, irreversible cognitive dysfunction or psychosocial
             issues that are likely to impair compliance with the study protocol and LVAS
             management

          9. History of confirmed, untreated Abdominal Aortic Aneurysm (AAA) &gt; 5 cm in diameter
             within 6 months of enrollment

         10. Presence of an active, uncontrolled infection

         11. Intolerance to anticoagulant or antiplatelet therapies or any other
             peri/post-operative therapy that the investigator will require based upon the
             patients' health status

         12. Presence of any one of the following risk factors for indications of severe end organ
             dysfunction or failure:

               -  An INR ≥ 2.0 not due to anticoagulation therapy

               -  Total bilirubin &gt; 43 umol/L (2.5 mg/dl), shock liver, or biopsy proven liver
                  cirrhosis

               -  History of severe chronic obstructive pulmonary disease (COPD) defined by
                  FEV1/FVC &lt; 0.7, and FEV1 &lt;50% predicted

               -  Fixed pulmonary hypertension with a most recent PVR ≥ 8 Wood units that is
                  unresponsive to pharmacologic intervention

               -  History of stroke within 90 days prior to enrollment, or a history of
                  cerebrovascular disease with significant (&gt; 80%) uncorrected carotid artery
                  stenosis

               -  Serum Creatinine ≥ 221 umol/L (2.5 mg/dl) or the need for chronic renal
                  replacement therapy

               -  Significant peripheral vascular disease (PVD) accompanied by rest pain or
                  extremity ulceration

         13. Patient has moderate to severe aortic insufficiency without plans for correction
             during pump implant

         14. Pre albumin &lt; 150 mg/L (15mg/dL) or Albumin &lt; 30g/L (3 g/dL) (if only one available);
             pre albumin &lt; 150 mg/L (15mg/dL) and Albumin &lt; 30g/L (3 g/dL) (if both available)

         15. Planned Bi-VAD support prior to enrollment

         16. Patient has known hypo or hyper coagulable states such as disseminated intravascular
             coagulation and heparin induced thrombocytopenia

         17. Participation in any other clinical investigation that is likely to confound study
             results or affect the study

         18. Any condition other than HF that could limit survival to less than 24 months

         19. Patients actively listed for heart transplant (this exclusion applies only after
             commercial approval of the HM3 for short-term use)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Poornima Sood</last_name>
    <role>Study Director</role>
    <affiliation>St. Jude Medical</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carrie Vooght</last_name>
    <email>carrie.vooght@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Baptist Health Medical Center - Little Rock</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Ford</last_name>
      <email>amy.ford@baptist-health.org</email>
    </contact>
    <investigator>
      <last_name>John Ransom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Barone</last_name>
      <email>heather.barone@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Francisco Arabia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanee Schimmel</last_name>
      <email>mschimmel@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Eric Adler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sutter Memorial Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Holmes-Rees</last_name>
      <email>holmerd@sutterhealth.org</email>
    </contact>
    <investigator>
      <last_name>Robert Kincade, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sharp Memorial Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcia Stahovich</last_name>
      <email>marcia.stahovich@sharp.com</email>
    </contact>
    <investigator>
      <last_name>Robert Adamson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Redford</last_name>
      <email>redforj@sutterhealth.org</email>
    </contact>
    <investigator>
      <last_name>Brett Sheridan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Vesom</last_name>
      <email>nvesom@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>William Hiesinger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Barron</last_name>
      <email>jose.barron@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Andreas Brieke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynn Wilson</last_name>
      <email>lynn.wilson@ynhh.org</email>
    </contact>
    <investigator>
      <last_name>Pramod Bonde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Ahmed</last_name>
      <email>sara.ahmed@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Farooq Sheikh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shands Hospital @ University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Cobb</last_name>
      <email>jessica.cobb@surgery.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Beaver, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Singleton</last_name>
      <email>Christine.singleton@flhosp.org</email>
    </contact>
    <investigator>
      <last_name>Scott Silvestry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebekah Fuechslin</last_name>
      <email>rebekahefuechslin@tgh.org</email>
    </contact>
    <investigator>
      <last_name>Christiano Caldeira, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Picardi</last_name>
      <email>kristina.picardi@piedmont.org</email>
    </contact>
    <investigator>
      <last_name>David Dean, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jayne Thompson</last_name>
      <email>sjdanle@emory.edu</email>
    </contact>
    <investigator>
      <last_name>J. David Vega, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Dreisbach</last_name>
      <email>Alexander.Dreisbach@nm.org</email>
    </contact>
    <investigator>
      <last_name>Allen Anderson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shanna Davis</last_name>
      <email>sdavis13@medicine.bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Gabriel Sayer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advocate Christ Medical Center</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60453</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Gallagher</last_name>
      <email>colleen.gallagher@advocatehealth.com</email>
    </contact>
    <investigator>
      <last_name>Antone Tatooles, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IU Health/Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Adams</last_name>
      <email>hadams3@iuhealth.org</email>
    </contact>
    <investigator>
      <last_name>I-Wen Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Regina Margiotti</last_name>
      <email>ramargio@stvincent.org</email>
    </contact>
    <investigator>
      <last_name>Mary Walsh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Traci Parks</last_name>
      <email>traci-parks@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Jay Bhama, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kentucky - Saha Cardiovascular Research Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Isaacs</last_name>
      <email>jennifer.isaacs@uky.edu</email>
    </contact>
    <investigator>
      <last_name>Maya Guglin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jewish Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Blanton</last_name>
      <email>mary.blanton@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Mark Slaughter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Henry</last_name>
      <email>jessica.henry@ochsner.org</email>
    </contact>
    <investigator>
      <last_name>Aditya Bansai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Unversity Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Obichukwu Ezennia</last_name>
      <email>oezenni1@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Ryan Tedford, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sumner Klimarx</last_name>
      <email>SKILMARX@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>David D'Alessandro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham &amp; Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Anello</last_name>
      <email>manello@partners.org</email>
    </contact>
    <investigator>
      <last_name>Michael Givertz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lydia McGowan</last_name>
      <email>lydiamcg@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Francis Pagani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neha Gupta</last_name>
      <email>ngupta6@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Hassan Nemeh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Butterworth Hospital</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katy Wachter</last_name>
      <email>katy.wachter@spectrumhealth.org</email>
    </contact>
    <investigator>
      <last_name>Marzia Leacche, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sarah Dennis</last_name>
      <email>sarah.dennis@allina.com</email>
    </contact>
    <investigator>
      <last_name>Karol Mudy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Medical Center, Fairview</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Greer</last_name>
      <email>gree1543@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Ranjit John, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>June Kendall-Thomas</last_name>
      <email>kendallthomas.june15@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>John Stulak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barnes Jewish Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Sutton</last_name>
      <email>suttont@wudosis.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Akinobu Itoh, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>63198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalie Kamtz</last_name>
      <email>natalie.kamtz@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>John Um, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Policastro</last_name>
      <email>Patricia.Policastro@rwjbh.org</email>
    </contact>
    <investigator>
      <last_name>Margarita Camacho, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magdalena Mamczur-Madry</last_name>
      <email>mmamczur@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Ulrich Jorde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mt. Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raj Thapar</last_name>
      <email>raj.thapar@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Anelechi Anyanwu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadia Sookraj</last_name>
      <email>ns3125@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Yoshifumi Naka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Caufield, RN</last_name>
      <email>lori_caufield@urmc.rochester.edu</email>
    </contact>
    <investigator>
      <last_name>Leway Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Reed</last_name>
      <email>tgjreed@email.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Jason Katz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krystal Winkler</last_name>
      <email>krystal.winkler@carolinas.org</email>
    </contact>
    <investigator>
      <last_name>Eric Skipper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sanjeev Gulati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Han Billard</last_name>
      <email>han.billard@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Carmelo Milano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals of Cleveland</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Huntington</last_name>
      <email>Lauren.Huntington@UHhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Guilherme Oliveira, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Gus</last_name>
      <email>gusb@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Edward Soltesz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neha Mali</last_name>
      <email>neha.mali@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Bassam Shukrallah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>INTEGRIS Baptist Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrienne Maximin</last_name>
      <email>Adrienne.Maximin@integrisok.com</email>
    </contact>
    <investigator>
      <last_name>James Long, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Douglas Horstmanshoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Halvorson</last_name>
      <email>halvorsj@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Frederick Tibayan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hershey</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dena Jefferson</last_name>
      <email>meaton@hmc.psu.edu</email>
    </contact>
    <investigator>
      <last_name>Walter Pae, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Laverty-Wilson</last_name>
      <email>eva.laverty-wilson@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Pavan Atluri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Adams</last_name>
      <email>suzanne.adams@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>John Entwistle III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Machen</last_name>
      <email>laurie.machen@ahn.org</email>
    </contact>
    <investigator>
      <last_name>Stephen Bailey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15323</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel McGarigle</last_name>
      <email>mcgarglerd@ph.upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Kormos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vijay Paladugu</last_name>
      <email>paladugc@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Adrian Van Bakel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Thomas West Hospital</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cissie Gregory</last_name>
      <email>mgregory@sth.org</email>
    </contact>
    <investigator>
      <last_name>Don Chomsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Slinger</last_name>
      <email>lisa.slinger@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Mary Keebler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Bonilla</last_name>
      <email>Carmen.Bonilla@BSWHealth.org</email>
    </contact>
    <investigator>
      <last_name>Shelley Hall, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann Health Systems</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabella Candelaria</last_name>
      <email>isabella.n.candelaria@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Igor Gregoric, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Methodist Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Barr</last_name>
      <email>ddbar@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>Brian Bruckner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Heart Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felicia Trent</last_name>
      <email>ftrent@texasheart.org</email>
    </contact>
    <investigator>
      <last_name>Masahiro Ono, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah Hospital and Clinics</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Elmer</last_name>
      <email>ashley.elmer@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Craig Selzman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia Medical Center</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Simon</last_name>
      <email>rmg5r@hscmail.mcc.virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Leora Yarboro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vinita Gupta</last_name>
      <email>vinita.gupta@inova.org</email>
    </contact>
    <investigator>
      <last_name>Shashank Desai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ramesh Singh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melinda Bullivant</last_name>
      <email>mmbulliv@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Christopher Barreiro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bon Secours St. Mary's Hospital</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole McWalters</last_name>
      <email>nicole_mcwalters@bshsi.org</email>
    </contact>
    <investigator>
      <last_name>Steven Fiser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinfeng Han</last_name>
      <email>jhan@vcu.edu</email>
    </contact>
    <investigator>
      <last_name>Daniel Tang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kent Shively</last_name>
      <email>raackek@u.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Nahush Mokadam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudius Mahr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin Hospitals and Clinics</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaelin Grant</last_name>
      <email>grantk@surgery.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Takushi Kohmoto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Miller</last_name>
      <email>margaret.miller@aurora.org</email>
    </contact>
    <investigator>
      <last_name>Francis Downey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Netuka I, Sood P, Pya Y, Zimpfer D, Krabatsch T, Garbade J, Rao V, Morshuis M, Marasco S, Beyersdorf F, Damme L, Schmitto JD. Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study. J Am Coll Cardiol. 2015 Dec 15;66(23):2579-2589. doi: 10.1016/j.jacc.2015.09.083.</citation>
    <PMID>26670056</PMID>
  </reference>
  <reference>
    <citation>Uriel N, Adatya S, Mehra MR. Evolution in Mechanical Circulatory Support: Are We at the Precipice of a Disruptive Innovation? J Am Coll Cardiol. 2015 Dec 15;66(23):2590-2593. doi: 10.1016/j.jacc.2015.10.028.</citation>
    <PMID>26670057</PMID>
  </reference>
  <reference>
    <citation>Schmitto JD, Hanke JS, Rojas SV, Avsar M, Haverich A. First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III). J Heart Lung Transplant. 2015 Jun;34(6):858-60. doi: 10.1016/j.healun.2015.03.001. Epub 2015 Mar 7.</citation>
    <PMID>25920932</PMID>
  </reference>
  <reference>
    <citation>Netuka I, Kvasnička T, Kvasnička J, Hrachovinová I, Ivák P, Mareček F, Bílková J, Malíková I, Jančová M, Malý J, Sood P, Sundareswaran KS, Connors JM, Mehra MR. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. J Heart Lung Transplant. 2016 Jul;35(7):860-7. doi: 10.1016/j.healun.2016.05.019. Epub 2016 May 31.</citation>
    <PMID>27435529</PMID>
  </reference>
  <reference>
    <citation>Bourque K, Cotter C, Dague C, Harjes D, Dur O, Duhamel J, Spink K, Walsh K, Burke E. Design Rationale and Preclinical Evaluation of the HeartMate 3 Left Ventricular Assist System for Hemocompatibility. ASAIO J. 2016 Jul-Aug;62(4):375-83. doi: 10.1097/MAT.0000000000000388.</citation>
    <PMID>27195742</PMID>
  </reference>
  <reference>
    <citation>Hanke JS, Haverich A, Schmitto JD. Exchange of a HeartMate II left ventricular assist device with a HeartMate 3 pump. J Heart Lung Transplant. 2016 Jul;35(7):944-6. doi: 10.1016/j.healun.2016.03.013. Epub 2016 Mar 30.</citation>
    <PMID>27160494</PMID>
  </reference>
  <reference>
    <citation>Heatley G, Sood P, Goldstein D, Uriel N, Cleveland J, Middlebrook D, Mehra MR; MOMENTUM 3 Investigators. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. J Heart Lung Transplant. 2016 Apr;35(4):528-36. doi: 10.1016/j.healun.2016.01.021. Epub 2016 Jan 30. Review.</citation>
    <PMID>27044532</PMID>
  </reference>
  <reference>
    <citation>Schulz A, Stepanenko A, Krabatsch T. HeartMate 3 implantation via left lateral thoracotomy with outflow graft anastomosis to the descending aorta. J Heart Lung Transplant. 2016 May;35(5):690-2. doi: 10.1016/j.healun.2016.01.004. Epub 2016 Jan 15.</citation>
    <PMID>26944673</PMID>
  </reference>
  <reference>
    <citation>Stansfield WE, Rao V. HeartMate 3: Facing the challenge of past success. J Thorac Cardiovasc Surg. 2016 Sep;152(3):683-5. doi: 10.1016/j.jtcvs.2016.04.048. Epub 2016 Apr 22.</citation>
    <PMID>27210469</PMID>
  </reference>
  <reference>
    <citation>Takayama H. Did you like Terminator 3 better than Terminator 2? &quot;Rise of machines&quot; with HeartMate 3? J Thorac Cardiovasc Surg. 2016 Sep;152(3):686-7. doi: 10.1016/j.jtcvs.2016.05.044. Epub 2016 Jun 2.</citation>
    <PMID>27349284</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2016</study_first_submitted>
  <study_first_submitted_qc>September 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2016</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>LVAS</keyword>
  <keyword>Ventricular Dysfunction</keyword>
  <keyword>Cardiomyopathy</keyword>
  <keyword>Heart Disease</keyword>
  <keyword>Cardiovascular Disease</keyword>
  <keyword>Heart-assist devices</keyword>
  <keyword>Thoratec Corporation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

